Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ADIL
- Price
- 0.69
- Stock movement down
- -0.03 (-4.31%)
- Company name
- Adial Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 4.39M
- Ent value
- 19.07K
- Price/Sales
- 136.28
- Price/Book
- 0.75
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -38.36%
- 1 year return
- -69.38%
- 3 year return
- -74.53%
- 5 year return
- -53.92%
- 10 year return
- -
Last updated: 2025-04-18
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ADIL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 136.28 |
| Price to Book | 0.75 |
| EV to Sales | 0.59 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 6.41M |
| EPS (TTM) | -1.91 |
| FCF per share (TTM) | -0.80 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 32.25K |
| Gross profit (TTM) | -282.00 |
| Operating income (TTM) | -6.34M |
| Net income (TTM) | -11.13M |
| EPS (TTM) | -1.91 |
| EPS (1y forward) | -1.42 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -0.87% |
| Operating margin (TTM) | -19672.90% |
| Profit margin (TTM) | -34505.55% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.20M |
| Net receivables | 0.00 |
| Total current assets | 5.62M |
| Goodwill | 0.00 |
| Intangible assets | 3.49K |
| Property, plant and equipment | 0.00 |
| Total assets | 6.71M |
| Accounts payable | 318.12K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 829.05K |
| Total liabilities | 829.05K |
| Shareholder's equity | 5.88M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.05M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -4.65M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -189.11% |
| Return on Assets | -165.75% |
| Return on Invested Capital | -189.11% |
| Cash Return on Invested Capital | -78.96% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.70 |
| Daily high | 0.73 |
| Daily low | 0.68 |
| Daily Volume | 18K |
| All-time high | 208.25 |
| 1y analyst estimate | 7.50 |
| Beta | 1.30 |
| EPS (TTM) | -1.91 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 12 May 2025 |
Downside potential
Loading...
Downside potential data
| ADIL | S&P500 | |
| Current price drop from All-time high | -99.67% | -14.12% |
| Highest price drop | -99.70% | -56.47% |
| Date of highest drop | 4 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -80.46% | -11.07% |
| Avg time to new high | 154 days | 12 days |
| Max time to new high | 1574 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
4.39M
Marketcap category
Small-cap
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Employees
4
Website
Investor relations
-
SEC filings
CEO
William B. Stilley
Country
USA
City
Charlottesville
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page